Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 17 of 17

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract March 2012

Effect Of Intravitreal Injection Technique On Intraocular Pressure

Katrina A. Mears; Sophia I. Pachydaki

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):883.

ARVO Annual Meeting Abstract April 2010

Training Experience with Sutureless 23-Gauge Pars Plana Vitrectomy: My First 99 Sclerotomies

S. I. Pachydaki; G. J. Parlitsis; S. W. Lee; R. V. P. Chan; S. Kiss; M. Nissen; D. J. D' Amico

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):2568.

ARVO Annual Meeting Abstract May 2007

Safety and Efficacy of Torsional Phacoemulsification Performed by Ophthalmology Residents

S. I. Pachydaki; J. Y. Kim; N. Brar; S. L. Cremers

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):1076.

ARVO Annual Meeting Abstract May 2006

Effect of Systemic Administration of FK506 in a Rat Model of Retinal Detachment

S.I. Pachydaki; L. Sobrin; T. Nakazawa; D.N. Zacks; J. Miller; C.L. Grosskreutz

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):1045.

Retina August 2005

The RAGE Axis in Early Diabetic Retinopathy

PDF

Gaetano R. Barile; Sophia I. Pachydaki; Samir R. Tari; Song E. Lee; Christine M. Donmoyer; Wanchao Ma; Ling Ling Rong; Loredana G. Buciarelli; Thoralf Wendt; Heidi Hörig; Barry I. Hudson; Wu Qu; Alan D. Weinberg; Shi Fang Yan; Ann Marie Schmidt
TAGS: diabetic retinopathy, mice, rage, retina, hyperglycemic agents, vascular lesions, pathophysiology
Invest. Ophthalmol. Vis. Sci.. 2005; 46(8):2916-2924. https://doi.org/10.1167/iovs.04-1409

ARVO Annual Meeting Abstract May 2005

Expression of Cell Cycle–Related Proteins( Ki–67, PCNA, Cyclin E, CDK2) and Apoptosis Markers( Active Caspase–3, p85–PARP) in Vitreoretinal Disorders( PVR, PDR, Macular Pucker)

X. Zhang; G.R. Barile; L. Li; H. Chen; X. Zhu; S. Pachydaki; W.M. Schiff; J.R. Sparrow; S. Chang

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):5128.

ARVO Annual Meeting Abstract May 2005

Effect of Systemic Neuroprotective Agents on Photoreceptor Apoptosis in a Rat Model of Retinal Detachment

L. Sobrin; S.I. Pachydaki; T. Nakazawa; C.L. Grosskreutz; D.N. Zacks; J.W. Miller

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):5521.

ARVO Annual Meeting Abstract May 2005

Characterization of Effects of Systemic Antibiotics in a Rat Model of Retinal Detachment

S.I. Pachydaki; L. Sobrin; T. Nakazawa; C.L. Grosskreutz; D.N. Zacks; J.W. Miller

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):5572.

ARVO Annual Meeting Abstract May 2004

HNE–adducts, AGEs, RAGE and VEGF in Blue Light Irradiated A2E–laden RPE.

J.R. Sparrow; B. Cai; J. Zhou; S. Kim; S. Pachydaki; K. Nakanishi; A. Schmidt

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):1807.

ARVO Annual Meeting Abstract May 2004

Blockade of RAGE supresses hypoxia–induced Egr–1 expression in the retina

S.R. Tari; S.E. Lee; J.J. Tseng; D. Onat; S.I. Pachydaki; H. Hörig; D.N. Moroziewicz; S.F. Yan; A.M. Schmidt; G.R. Barile

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):1187.

ARVO Annual Meeting Abstract May 2003

Phenotype-Genotype Correlation in Patients With the Goldmann-Favre Syndrome

C.C. Klaver; S. Pachydaki; L.A. Yannuzzi; S.J. Huang; P. Gouras; R. Allikmets; I.A. Barbazetto

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):4938.

ARVO Annual Meeting Abstract May 2003

Induction of PVR in a Murine Model: Dispase-induced Disease Progresses in the Presence of a Retinal Tear

S.E. Lee; S.I. Pachydaki; M.P. Weisberg; S.R. Tari; A.M. Schmidt; S. Chang; G.R. Barile

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):3010.

ARVO Annual Meeting Abstract May 2003

S100/Calgranulin and RAGE Expression in PDR & PVR

S.R. Tari; S.I. Pachydaki; S.E. Lee; W.M. Schiff; S. Chang; A.M. Schmidt; G.R. Barile

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):3039.

ARVO Annual Meeting Abstract May 2003

Accelerated Vascular Changes of Nonproliferative Diabetic Retinopathy in a Murine Model of Diabetes

G.R. Barile; S.I. Pachydaki; S.R. Tari; S.E. Lee; L.L. Rong; L.G. Buciarelli; T. Wendt; C. Sakal; D.M. Stern; A.M. Schmidt

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):3294.

ARVO Annual Meeting Abstract May 2003

Electrophysiological Findings in a Murine Model of Diabetes

S.I. Pachydaki; S.R. Tari; C.M. Donmoyer; K. Lai; S.E. Lee; A.M. Schmidt; G.R. Barile

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):3873.

ARVO Annual Meeting Abstract December 2002

Cell proliferation and Apoptosis in Vitreoretinal Disorders( PVR, PDR, Macular Pucker): Expression of Ki-67( MIB-1), PCNA, Cyclin E, CDK4, Caspase-3 and PARP

X Zhang; GR Barile; S Pachydaki; D Liu; WM Schiff; JR Sparrow; S Chang

Invest. Ophthalmol. Vis. Sci.. 2002; 43(13):3619.

ARVO Annual Meeting Abstract December 2002

Expression of Receptor for Advanced Glycation End Products (RAGE) and Its Ligands S100 / Calgranulins and Amphoterin Is Increased in the Vitreous Cavity of Patients with Proliferative Retinal Disease

SI Pachydaki; S Chang; X Zhang; G Cataldegirmen; LL Rong; AM Schmidt; GR Barile

Invest. Ophthalmol. Vis. Sci.. 2002; 43(13):3861.

Advertisement